Missouri meth bills
This article was originally published in The Tan Sheet
Executive SummaryRetail display of single-ingredient OTCs containing ephedrine, pseudoephedrine, or phenylpropanolamine would be limited to behind the counter or within six feet of a checkout register in stores without anti-theft systems under Missouri House Bill 470. Bill passed state assembly April 8, was referred to Senate Judiciary Committee, where an April 23 hearing is scheduled. Intended to limit availability of methamphetamine ingredients, bill also would block sales of more than six grams, or two packages, of any of the products. Senate Bill 442, also awaiting a hearing, includes ban on more than six grams of products and might incorporate other elements of HB 470. In testimony before Missouri Senate, CHPA has claimed bill will unduly restrict retailers without significant impact on crime, association says...
You may also be interested in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.
Laparoscopic power morcellation to remove uterine fibroids should only be performed with the use of a compatible containment system, and only on women younger than 50, the US FDA said in a newly published safety communication and draft guidance document. See what the president of the gynecologic trade group AAGL, Jubilee Brown, said about it here.